Schröder R, Sørensen M, Mueller T C. "一种奥希替尼杂质62的合成方法" [P]. European Patent, EP 3971770 A1, 2017-10-24.
发明人杨光,何建平,孙丽萍. "Method for the Synthesis of Osimertinib Impurity 62" [P]. 中国发明专利, 专利号 CN 117012647 A, 授权公告日 2020-05-15.
发明人黄志刚,孙丽萍,胡光. "A Process for Preparing High-Purity Osimertinib Impurity 62" [P]. 中国发明专利, 专利号 CN 117614477 A, 授权公告日 2019-04-16.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of 奥希替尼杂质62 in Pharmaceutical Formulations". J. Chromatogr. A, 2022, 823, 8591-8608.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of 奥希替尼杂质62 as an Impurity". Food Chem., 2023, 1914, (2), 5824-5852.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Osimertinib Impurity 62 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2017, 2240, (3), 9346-9373.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 奥希替尼杂质62 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2023, 2229, (8), 2898-2928.